Cerebral dopamine neurotrophic factor (Herantis Pharma)

N/A

Report date: 2025/07/08 20:00:08

Base Information

Drug NameCerebral dopamine neurotrophic factor (Herantis Pharma)
Drug Alias Namerecombinant human cerebral dopamine neurotrophic factorCDNFHER-096
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionNeurons modulators
TargetsNot applicable
Therapy Area/IndicationsNeurodegenerative DiseasesMovement DisordersParkinson Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenFinland
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of HelsinkiHerantis PharmaRenishaw Plc.
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRenishaw Plc.Herantis Pharma Plc.
Active IndicationsN/A
Inactive IndicationsNeurodegenerative DiseasesMovement DisordersParkinson Disease +[5] 

Other Information

ATC CodeN/A
Related LinksN/A